Endeavor

Autologous vs. Allogeneic CAR T

Dr. Patrick Hwu discusses the benefits of off-the-shelf CAR T

Does CAR T Show Promise for Solid Tumors?

Dr. Patrick Hwu tackles the topic in this episode of the Moffitt Medical Minute

Moffitt Highlighted in London Museum Exhibit

Cancer center is one of the only U.S. institutions included in the history of cancer showing

Moffitt’s Newest Partnership to Advance Cell Therapies for Solid Tumors

Strategic alliance with Turnstone Biologics Corp. focuses on tumor infiltrating lymphocyte therapies

Can Gene-Edited CAR T Improve Non-Hodgkin Lymphoma Outcomes?

New product involves dual targeting, signaling technology and gene editing

TIL Therapy Shows Promise in Non-Small Cell Lung Cancer

Cellular therapy gave scuba diver Deborah Barker a new option for beating the disease

Every Moment Matters: A Father’s Perspective

Melanoma survivor details juggling first-time fatherhood through cancer

Can the Gut Microbiome Predict Response to Cancer Treatment?

New study suggests so for recurrent metastatic head and neck cancer patients

Moffitt Researchers Use Explainable AI to Investigate and Predict the Survival Efficacy of Immunotherapy Drug

Data presented at ASCO help researchers get a deeper understanding of immune checkpoint inhibitors efficiency in patients